Kazia Therapeutics Ltd
Nasdaq: KZIA
- Raised $55 million (2025)
- 5 clinical trials
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Korsana Biosciences, Inc.
Nasdaq: KRSA
- Raised $5 million (2023)
- 13 clinical trials
- Founded 2018
Medicenna Therapeutics Corp.
OTC: MDNAF
- Raised $15 million (2024)
- 2 clinical trials, 1 active
- Founded 2015
Moonlight Therapeutics Inc.
- Raised $2.4 million (2024)
- 1 clinical trial, 1 active
- Research grants: $14 million
Pure Green Pharmaceuticals Inc.
- Raised $5.4 million (2022)
- 7 clinical trials
- Research grants: $4.1 million
- Founded 2019
Quantum Cyber N.V.
Nasdaq: QUCY
- Raised $14 million (2024)
- 2 clinical trials, 2 active
- Founded 2021
Sapience Therapeutics, Inc.
- Raised $8 million (2020)
- 3 clinical trials, 3 active
- Research grants: $9.4 million
- Founded 2015
Seaport Therapeutics, Inc.
Nasdaq: SPTX
- Raised $226 million (2024)
- 2 clinical trials, 2 active
- Founded 2024
Skye Bioscience, Inc.
Nasdaq: SKYE
- Raised $40 million (2024)
- 2 clinical trials, 1 active
- Founded 2011
Synedgen, Inc.
- Raised $1.8 million (2024)
- 2 clinical trials, 1 active
- Research grants: $3.1 million
- Founded 2009
Trethera Corp
- Raised $250,000 (2025)
- 1 clinical trial, 1 active
- Research grants: $25 million
- Founded 2015
Asuragen Inc
- Raised $7.5 million (2013)
- FDA-cleared or approved devices
- Research grants: $16 million
Biosensics LLC
- 11 clinical trials, 7 active
- 1 FDA-registered device site
- Research grants: $110 million
Biotex, Inc.
- 5 clinical trials, 1 active
- FDA-cleared or approved devices
- Research grants: $33 million
Piraeus Medical, Inc.
- Raised $3.6 million (2026)
- FDA-cleared or approved devices
- Research grants: $4.9 million
- Founded 2021
Can-Fite BioPharma Ltd.
NYSE: CANF
- Raised $10 million (2021)
- 22 clinical trials, 4 active
Masimo Corp
- 106 clinical trials, 2 active
- FDA-cleared or approved devices
Synapse Biomedical Inc
- Raised $433,358 (2010)
- 10 clinical trials
- FDA-cleared or approved devices
- Research grants: $467,170
4D Molecular Therapeutics, Inc.
Nasdaq: FDMT
- Raised $90 million (2018)
- 10 clinical trials, 9 active
- Founded 2015
Eikon Therapeutics, Inc.
Nasdaq: EIKN
- Raised $351 million (2025)
- 10 clinical trials, 6 active
- Founded 2019
Fulcrum Therapeutics, Inc.
Nasdaq: FULC
- Raised $68 million (2020)
- 10 clinical trials, 1 active
- Founded 2015
Synlogic, Inc.
OTC: SYBX
- Raised $80 million (2019)
- 10 clinical trials
- Founded 2007
Perrigo Co
- 8 clinical trials
- FDA-cleared or approved devices
- 3 FDA-registered drug sites
TYBR Health, Inc.
- Raised $7.1 million (2025)
- FDA-cleared or approved devices
- Research grants: $1.6 million
- Founded 2020
Staar Surgical Co
Nasdaq: STAA
- 8 clinical trials, 2 active
- FDA-cleared or approved devices
Recombinetics, Inc
- Raised $7.7 million (2019)
- 2 FDA-registered drug sites
- Research grants: $17 million
Allogene Therapeutics, Inc.
Nasdaq: ALLO
- Raised $412 million (2018)
- 9 clinical trials, 5 active
- Founded 2017
Aura Biosciences, Inc.
Nasdaq: AURA
- Raised $80 million (2021)
- 9 clinical trials, 6 active
- Founded 2009
Carisma Therapeutics Inc.
OTC: CARM
- Raised $38 million (2021)
- 9 clinical trials
- Founded 2008
Creative Medical Technology Holdings, Inc.
Nasdaq: CELZ
- Raised $17 million (2022)
- 4 clinical trials, 3 active
EyePoint, Inc.
Nasdaq: EYPT
- Raised $16 million (2021)
- 19 clinical trials, 5 active
Harrow, Inc.
Nasdaq: HROW
- Raised $11 million (2021)
- 4 clinical trials, 2 active
Holobiome, Inc.
- Raised $6.6 million (2024)
- 1 clinical trial, 1 active
- Research grants: $3.9 million
- Founded 2015
Intellia Therapeutics, Inc.
Nasdaq: NTLA
- Raised $70 million (2015)
- 10 clinical trials, 7 active
- Founded 2014
Korro Bio, Inc.
Nasdaq: KRRO
- Raised $42 million (2020)
- 9 clinical trials, 1 active
- Founded 2014
LeonaBio, Inc.
Nasdaq: LONA
- Raised $89 million (2020)
- 9 clinical trials, 1 active
- Founded 2011
Leuko Labs, Inc.
- Raised $1.2 million (2019)
- 4 clinical trials, 1 active
- Research grants: $12 million
- Founded 2017
Perspective Therapeutics, Inc.
NYSE: CATX
- Raised $87 million (2024)
- 4 clinical trials, 3 active
Axsome Therapeutics, Inc.
Nasdaq: AXSM
- Raised $2.5 million (2015)
- 37 clinical trials, 12 active
- Founded 2012
Zeltiq Aesthetics Inc
- 39 clinical trials
- FDA-cleared or approved devices
Cardiva Medical, Inc.
- Raised $45 million (2020)
- 6 clinical trials
- FDA-cleared or approved devices
Organogenesis Inc
- 36 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $304,510
Procter & Gamble
- 105 clinical trials, 2 active
- FDA-cleared or approved devices
- 6 FDA-registered drug sites
Armis Biopharma, Inc.
- Raised $1 million (2025)
- FDA-cleared or approved devices
- Research grants: $4.2 million
ARS Pharmaceuticals, Inc.
Nasdaq: SPRY
- Raised $55 million (2021)
- 8 clinical trials, 2 active
- Founded 2015
Arsenal Medical, Inc.
- Raised $6 million (2019)
- 2 clinical trials, 2 active
- Research grants: $8.7 million
- Founded 2011
CairnSurgical, Inc.
- Raised $3.3 million (2019)
- 2 clinical trials
- Research grants: $13 million
- Founded 2017
Immunophotonics, Inc.
- Raised $1.5 million (2024)
- 2 clinical trials, 2 active
- Research grants: $4.8 million
- Founded 2012
Invivyd, Inc.
Nasdaq: IVVD
- Raised $24 million (2022)
- 8 clinical trials, 3 active
- Founded 2020
Larimar Therapeutics, Inc.
Nasdaq: LRMR
- Raised $82 million (2020)
- 8 clinical trials, 2 active
- Founded 2005
Published company profiles only; counts update daily. Data licences